(NYSE: WAT) Waters's forecast annual revenue growth rate of 7.19% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.9%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.08%.
Waters's revenue in 2026 is $3,105,638,000.On average, 25 Wall Street analysts forecast WAT's revenue for 2026 to be $202,179,977,040, with the lowest WAT revenue forecast at $195,035,808,240, and the highest WAT revenue forecast at $211,884,139,660. On average, 20 Wall Street analysts forecast WAT's revenue for 2027 to be $215,039,480,880, with the lowest WAT revenue forecast at $205,752,061,440, and the highest WAT revenue forecast at $226,708,289,920.
In 2028, WAT is forecast to generate $227,482,241,540 in revenue, with the lowest revenue forecast at $215,337,154,580 and the highest revenue forecast at $241,472,905,440.